Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

SkylineDx’s SKY92 test with fluorescence in situ hybridisation testing led to more accurate identification of high-risk ...

Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...

Patients who received cilta-cel had improvements in progression-free survival and overall survival if they had sustained a minimal residual disease-negative complete response or better for at least 1 ...